TrivarX Limited (ASX: TRI.AX) AI-Powered Stock Analysis
See how TrivarX Limited scores across key metrics like financial growth, valuation, and market position on the ASX, using AI-driven evaluation.
TRI.AX●ASX
HealthcareMedical - Healthcare Information Services
$0.02
$0.001(5.88%)
Australian Market opens in 2h 7m
TrivarX Limited (ASX: TRI.AX) AI-Powered Stock Analysis
See how TrivarX Limited scores across key metrics like financial growth, valuation, and market position on the ASX, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerTrivarX Limited (ASX: TRI.AX) Stock Overall Grade
TrivarX Limited's grade for its ASX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to TrivarX Limited's overall ASX stock rating.
Forecast
C+Score
55/100Financial Growth
CScore
40/100Fundamental Growth
DScore
35/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
70/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
C+Score
50/100TrivarX Limited (ASX: TRI.AX) AI-Powered Stock Analysis
On the ASX, TRI.AX demonstrates Normal performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (35/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (70/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the ASX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests Moderate divergence in outlook.(ASX: TRI.AX) Component Analysis Explained
Understand the key factors behind each TrivarX Limited (ASX: TRI.AX) stock grade, including financials, comparisons, and forecasts.